Effect of Blood Group on Ultrahigh Frequency Auditory Sensitivity

Abstract

Introduction Individuals with blood group O are reported to have reduced otoacoustic emissions (OAEs) compared with individuals with different blood groups.

Objective The present study attempted to determine if the blood group has any effect on high-frequency auditory sensitivity using ultrahigh-frequency audiometry and ultrahigh-frequency distortion product otoacoustic emissions (DPOAEs).

Methods High-frequency thresholds and high-frequency DPOAEs were measured in 60 individuals with normal hearing and different blood groups.

Results The results of the study showed that there was a significant reduction in DPOAE amplitude for individuals with blood group O compared with individuals with other blood groups. However, there was no significant difference in ultrahigh-frequency thresholds across the blood groups.

Conclusion This reduction in OAE amplitude may be attributed to a lower number of healthy outer hair cells in individuals with blood group O. Further studies on larger groups of individuals are essential for a better generalization of the results.

Keywords

noise-induced hearing loss - ABO blood group system - audiometry

• References

• 1 Plontke S, Zenner H-P. Current aspects of hearing loss from occupational and leisure noise. GMS Curr Top Otorhinolaryngol Head Neck Surg 2004; 3: Doc06
• 2 Henderson D, Subramaniam M, Boettcher FA. Individual susceptibility to noise-induced hearing loss: an old topic revisited. Ear Hear 1993; 14 (03) 152-168
• 3 Chow KT, McPherson B, Fuente A. Otoacoustic emissions in young adults: Effects of blood group. Hear Res 2016; 333: 194-200
• 4 Mehrparvar AH, Mirmohammadi SJ, Ghoreyshi A, Mollasadeghi A, Loukzadeh Z. High-frequency audiometry: a means for early diagnosis of noise-induced hearing loss. Noise Health 2011; 13 (55) 402-406
• 5 Singh Chauhan R, Saxena RK, Varshey S. The role of ultrahigh-frequency audiometry in the early detection of systemic drug-induced hearing loss. Ear Nose Throat J 2011; 90 (05) 218-222
• 6 van der Hulst RJ, Boeschoten EW, Nielsen FW, Struijk DG, Dreschler WD, Tange RA. Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin. ORL J Otorhinolaryngol Relat Spec 1991; 53 (01) 19-22
• 7 Kemp DT, Ryan S, Bray P. A guide to the effective use of otoacoustic emissions. Ear Hear 1990; 11 (02) 93-105
• 8 Sircar S. Principles of Medical Physiology. New York: Thieme; 2008: 161-162 p
• 9 Lashley FR. Clinical Genetics in Nursing Practice. 3rd ed. New York: Springer; 2005: 387-400 p
• 10 Somma G, Pietroiusti A, Magrini A. , et al. Extended high-frequency audiometry and noise induced hearing loss in cement workers. Am J Ind Med 2008; 51 (06) 452-462
• 11 Korres GS, Balatsouras DG, Tzagaroulakis A, Kandiloros D, Ferekidis E. Extended high-frequency audiometry in subjects exposed to occupational noise. B-ENT 2008; 4 (03) 147-155
• 12 Antonioli CAS, Momensohn-Santos TM, Benaglia TAS. High-frequency Audiometry Hearing on Monitoring of Individuals Exposed to Occupational Noise: A Systematic Review. Int Arch Otorhinolaryngol 2016; 20 (03) 281-289
• 13 Fernandes LC, Santos TMM. Tinnitus and normal hearing: a study on the transient otoacoustic emissions suppression. Rev Bras Otorrinolaringol (Engl Ed) 2016; 75 (03) 414-419
• 14 Yathiraj A, Vijayalakshmi CS. Phonemically balanced wordlist in Kannada. University of Mysore; 2005
• 15 Carhart R, Jerger JF. Preferred method for clinical determination of pure-tone thresholds. J Speech Hear Disord 1959; 24: 330-345
• 16 Kemp DT. Otoacoustic emissions, their origin in cochlear function, and use. Br Med Bull 2002; 63: 223-241
• 17 Lonsbury-Martin BL, Martin GK. Distortion-product otoacoustic emissions in 421 populations with normal hearing sensitivity. In: Robinette MS, Glattke TJ. Otoacoustic Emissions: Clinical Applications. 3rd ed. New York: Thieme; 2007: 107-130